Ferrer Internacional
Grupo Ferrer Internacional is a privately-held European pharmaceutical company based in Barcelona, specializing in research and development across multiple sectors, including pharmaceuticals, health, fine chemicals, and food. The company commercializes its human healthcare products in over 95 countries, supported by a network of 24 international affiliates and numerous partners and distributors. Ferrer is involved in the entire pharmaceutical value chain, encompassing activities from research and development to international marketing, as well as the development and manufacturing of raw materials and finished pharmaceuticals. Its research facilities are located in Spain and Germany, while its manufacturing sites are distributed across Europe and Latin America. Ferrer's diverse product portfolio includes prescription drugs, hospital equipment, personalized medicines, vaccines, and consumer healthcare products.
Top Stages
Past deals in Barcelona
ABAC Therapeutics
Series A in 2018
ABAC Therapeutics S.A., based in Barcelona, Spain, specializes in the development of precision antimicrobial agents aimed at treating multidrug-resistant (MDR) Gram-negative infections. Established in 2014, the company utilizes its innovative PasNas drug discovery platform to identify pathogen-specific antibacterial properties of various molecules. This platform not only focuses on potent antibacterial activity but also emphasizes the importance of favorable pharmacokinetics and toxicological profiles to enhance the likelihood of success in clinical development. ABAC Therapeutics seeks to provide first-in-class therapeutic alternatives for patients suffering from infections caused by antibiotic-resistant bacterial pathogens, particularly targeting the significant challenge posed by the major MDR Gram-negative bacteria. As of November 2019, the company operates as a subsidiary of Tibidabo Ventures.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.